21
HIV-1 Peptide Immunisation of Individuals in West Africa to Prevent Disease
Condition(s): Aids, Cdc Group I Last Updated: September 13, 2012Completed
213 Clinical Trials for: Immunity to HIV, Page 2 of 11
Hide Studies Not Seeking New Volunteers
22
Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects
Condition(s): HIV Infection Last Updated: November 21, 2012Completed
23
The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients
Condition(s): HIV Infections; Diarrhea; Bacterial Vaginosis Last Updated: January 29, 2009Active, not recruiting
24
A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART
Condition(s): HIV Infections Last Updated: June 23, 2005Completed
25
An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
Condition(s): HIV Infections; HCV Last Updated: January 26, 2012Completed
26
HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers
Condition(s): Healthy; HIV Infections Last Updated: October 19, 2007Completed
27
Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection
Condition(s): Acquired Immunodeficiency Syndrome; Mycobacterium Avium-Intracellulare Infection Last Updated: March 3, 2008Completed
28
Impact of Nutrition Intervention on HIV/AIDS Infected Patients
Condition(s): Human Immunodeficiency Virus (HIV); Acquired Immune Deficiency Syndrome (AIDS) Last Updated: July 27, 2010Completed
29
ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency
Condition(s): HIV Infections; Hepatitis B; Dyslipidemia Last Updated: June 27, 2007Completed
30
Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
Condition(s): HIV Infections; Cancer, Second Primary Last Updated: July 6, 2009Active, not recruiting
31
Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines
Condition(s): HIV Infections Last Updated: September 17, 2007Completed
32
Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
Condition(s): HIV Infections Last Updated: May 1, 2013Recruiting
33
Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects
Condition(s): Polio Immunity Last Updated: May 14, 2013Recruiting
34
Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers
Condition(s): Healthy; HIV Infection Last Updated: August 28, 2008Completed
35
Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)
Condition(s): HIV Infections Last Updated: February 12, 2010Completed
36
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
Condition(s): Human Immunodeficiency Virus; Human Papillomavirus- 6, 11, 16, 18; Adolescent; Papillomavirus Vaccines Last Updated: February 7, 2013Completed
37
A Study of GENEVAX-HIV, a Possible Vaccine
Condition(s): HIV Infections; HIV Seronegativity Last Updated: June 23, 2005Completed
38
Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox
Condition(s): HIV Infections; Chickenpox Last Updated: May 17, 2012Completed
39
Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy
Condition(s): HIV Infections Last Updated: May 9, 2012Completed
40
Pharmacokinetic Interactions Between DMPA and LPV/Rit Among HIV-Infected Women
Condition(s): HIV-1 Infection Last Updated: January 23, 2013Active, not recruiting
